We are proud to announce that our client 4D Pharma has successfully listed on the AIM market raising £16.5m and currently has a market capitalisation of over £60m. The AIM market is operated by the London Stock Exchange and is the most successful growth market in the world. Since its launch in 1995, over 3,000 companies have chosen to join AIM making it one of the largest international markets for smaller growing companies. 4D Pharma is is a pharmaceutical company focussing on developing a number of projects targeting important new therapeutic areas.
Stephen Dunbar, managing partner who lead the summ.it team said “We have worked with the directors of 4D Pharma on a number of assignments over the last 10 years and are extremely pleased to have assisted on such a successful flotation. This adds to a number of advisory AIM related roles we have had helping smaller businesses capture the capital they require for ambitious growth”.